Jay M. Moyes
Director · BioCardia, Inc.
- 2024
- Jul 8, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jay M. Moyes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Alessandra Cesano - $567K in PBYI purchases and sales in the last 12 months
- Alan H. Auerbach - $364K in PBYI purchases and sales in the last 12 months
- Gregg R. Honigblum - $322K in SINT purchases and sales in the last 12 months
- Adrian Senderowicz - $194K in PBYI purchases and sales in the last 12 months
- Troy Edward Wilson - $123K in PBYI purchases and sales in the last 12 months
- Simon H. Stertzer - $104K in BCDA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jay M. Moyes?
Jay M. Moyes is a corporate insider, tracked as Director of BioCardia, Inc. (BCDA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Jay M. Moyes last file a Form 4?
The most recent primary Form 4 on record is dated 8 July 2026, one of 7 filings going back to 2024.
Has Jay M. Moyes been buying or selling stock?
Recorded transactions: 2 open-market purchases ($14K) and 2 open-market sales ($234K) across all tracked filings.
